Torthaí cuardaigh - Fraser Symmans

Beachtaigh na torthaí
  1. 1
    Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions

    Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions de réir W. Fraser Symmans, Jiguan Liu, Daniel M. Knowles, Giorgio Inghirami

    Foilsithe / Cruthaithe 1995
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Fine-needle aspiration cytology of Hodgkin disease

    Fine-needle aspiration cytology of Hodgkin disease de réir David C. Chhieng, Joan Cangiarella, W. Fraser Symmans, Jean‐Marc Cohen

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

    Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma de réir Yun Gong, W. Fraser Symmans, Savitri Krishnamurthy, Shobha Patel, Nour Sneige

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Molecular Classification of Breast Cancer: Limitations and Potential

    Molecular Classification of Breast Cancer: Limitations and Potential de réir Lajos Pusztai, Chafika Mazouni, K. Anderson, Yun Wu, W. Fraser Symmans

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    The Bimodality Index: A criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data

    The Bimodality Index: A criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data de réir Jing Wang, Sijin Wen, W. Fraser Symmans, Lajos Pusztai, Kevin R. Coombes

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

    Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer de réir Jeffrey S. Ross, Christos Hatzis, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue

    Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue de réir Jialu Li, Chunxiao Fu, Terence P. Speed, Wenyi Wang, W. Fraser Symmans

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer

    Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer de réir Susan L. McGovern, Yuan Qi, Lajos Pusztai, W. Fraser Symmans, Thomas A. Buchholz

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine

    The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine de réir Jeffrey S. Ross, Elzbieta Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin, Gabriel N. Hortobágyi

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Mammotome core biopsy for mammary microcalcification

    Mammotome core biopsy for mammary microcalcification de réir Joan Cangiarella, Jerry Waisman, W. Fraser Symmans, Joshua Gross, Jean‐Marc Cohen, Horace Wu, Deborah Axelrod

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma

    Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma de réir Ibrahim Khalifeh, Constance T. Albarracin, Leslie K. Diaz, Fraser Symmans, Mary E. Edgerton, Rosa F. Hwang, Nour Sneige

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

    Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy de réir Florentia Peintinger, Bruno V. Sinn, Christos Hatzis, Constance T. Albarracin, Erinn Downs‐Kelly, Jerzy Morkowski, Rebekah Gould, W. Fraser Symmans

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Evaluation of biological pathways involved in chemotherapy response in breast cancer

    Evaluation of biological pathways involved in chemotherapy response in breast cancer de réir Attila Tordai, Jing Wang, Fabrice André, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers

    Effects of Tissue Handling on RNA Integrity and Microarray Measurements From Resected Breast Cancers de réir Christos Hatzis, Hongxia Sun, Hui Yao, R Hubbard, Funda Meric‐Bernstam, Gildy V. Babiera, Yun Wu, Lajos Pusztai, W. Fraser Symmans

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Targeted Therapy in Breast Cancer

    Targeted Therapy in Breast Cancer de réir Jeffrey S. Ross, Jonathan A. Fletcher, Kenneth J. Bloom, Gerald P. Linette, James Stec, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

    Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer de réir Jae K. Lee, Charles Coutant, Young Chul Kim, Yuan Qi, Dan Theodorescu, W. Fraser Symmans, Keith Baggerly, Roman Rouzier, Lajos Pusztai

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer

    Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer de réir Fabrice André, Christos Hatzis, K. Anderson, Christos Sotiriou, Chafika Mazouni, Jaime Mejia, Bailiang Wang, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 <sup>+</sup> :ERα <sup>−</sup> breast cancer

    Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2 <sup>+</sup> :ERα <sup>−</sup> breast cancer de réir Jeff C. Liu, Véronique Voisin, Gary D. Bader, Tao Deng, Lajos Pusztai, W. Fraser Symmans, Francisco J. Esteva, Sean E. Egan, Eldad Zacksenhaus

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues

    The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues de réir Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, Alexander J. Trevarton, Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

    Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy de réir Judy C. Boughey, Karla V. Ballman, Linda McCall, Elizabeth A. Mittendorf, W. Fraser Symmans, Thomas B. Julian, David R. Byrd, Kelly K. Hunt

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: